Skip to main content
. 2022 Jan 22;100(7):769–774. doi: 10.1111/aos.15094

Table 1.

Baseline characteristics.

N = 5216 First eye Second eye
Age 77.7 ± 7.3 79.3 ± 7.9
Sex, Female 69% 69%
CNV type
Not classified 20% 25%
Type 1 34% 32%
Type 2 30% 27%
RAP 14% 14%
PCV 2% 2%
Symptom duration
<0–2 month 40% 39%
2 ≤ 4 month 25% 24%
4–6 month 15% 14%
>6 month 20% 18%
Visual Acuity
ETDRS letters 57.6 ± 15.4 62.8 ± 14.7***
Snellen 0.35 ± 0.20 0.43 ± 0.23

At treatment start of first/second eye.

***

p < 0.0001.